32 Responses

  1. Bernard Farrell
    Bernard Farrell February 5, 2013 at 4:45 am | | Reply

    Thanks for a very comprehensive and interesting article. For those who can’t do the math, 80 hours is 3 and 1/3 days. Given a 2 hour warmup period it’s really 3 1/4 days. For anyone who hasn’t used a Dexcom that might be reasonable, otherwise….I wonder what this would do to the footprint of the proposed OmniPod.

    I do hope that Insulet and they anonymous partner will publish the data format for their new device(s). There’s a lot of interest in open data format support. I’m working with a number of people on this issue and we hope to put serious pressure on device makers to have open data formats as a requirement for new devices. Thanks DiabetesMine for also working on this issue.

  2. Bennet
    Bennet February 5, 2013 at 4:55 am | | Reply

    Thanks for the story Mike.

    It will be interesting to fill in the blanks. Among those is will the Pod people remain loyal to the pod or will integration tempt them to try other pumps. They seem a very loyal bunch.

    I would be curious to know how many podders currently use cgm. I recall reading some research someplace that suggested that CGM users were more willing to consider giving up their pumps than their sensors. That seems to suggest that there is a risk for Pod as a business but IMHO what really matter is the health of PWD. Slowing the advances of integrated care I see as unfortunate.



  3. Scott E
    Scott E February 5, 2013 at 5:21 am | | Reply

    Intriguing. As some of the earlier commenters noted, not only is the “usable” sensor time diminished (with all the warm-up periods), but this system removes choice from the patients. Assuming the only pods will be those with sensors, that would not only drive up the cost but, if someone prefers a different CGM, they’d be forced to wear two sensors (unlike the Medtronic system which doesn’t require a sensor with the Revel/Enlite). And since I can’t see an integrated cannula/sensor wire, that’s a needless hole through one’s flesh.

  4. Mike Ratrie
    Mike Ratrie February 5, 2013 at 7:07 am | | Reply

    Good reporting Mike, but not really so surprising given the way smartphone penetration has gone in the last 5 years.

    I was struck by this parenthetical in your story “(since insulin stays stable for about 80 hours)” – can you elaborate or provide more context?

  5. Betty
    Betty February 5, 2013 at 7:55 am | | Reply

    Insulet is missing the ball here. Even though the likelyhood of a workable 2- in -1 device is small, getting a pump and a cgm to BOTH read on a smartphone is more important than reducing 2 sites to one for us.

    My son wears both the omnipod and the dexcom. frankly the navigator was never a viable alternative when it was on the market and is still off the market here.

    until a different tubeless pump is on the market we will stay with omnipod, but ditching dexcom is a BAD idea. Getting the data on a smart phone for a pump and the CGM is going to be where people go.

    too many issues with 1 device IMHO. tossing a perfectly good sensor every time a cannula kinks or you have a small 200 unit device is not a great plan.

    Insulin in one spot for more that 48 hours isnt a great idea to begin with. I dont understand what they are thinking at this point. Maybe this is there way of saying “we are stuck and there will not be integration of any cgm in the forseeable future.”

    IF they refuse to work on this , I would bet the podders will leave as soon as a viable tubeless pump is on the market with a integration plan that makes sense.

    Everyone would love a 1 device on the body but when you look at the logistics of it, and really think about what it would mean, I think people can understand WHY it isnt a great idea with the current technology.

  6. Mike Rogers
    Mike Rogers February 5, 2013 at 9:45 am | | Reply

    My daughter uses both the Omnipod and the Dexcom G4. While she would prefer one site, the truth is the Dexcom Sensor lasts ( with restarting ) sometimes 3 weeks. The accuracy of the G4 is unbelievable. From my daughter’s perspective, there’s no way she’s going to switch from the omnipod to another pump because she prefers the lack of tubing.

    The lack of integration on the handheld side in the short term is really no big deal to her. The PDM woudn’t be a great place to see the graphs anyway.

    I see the lack of integration as a non-issue given news that G5 will transmit to the smartphone.

    If folks at insulet are reading, my daughter has one BIG request of you. The first gen and second gen PDMs have hard to push buttons that make a noise to her that is like nails on a chalkboard. Go to a touch interface or at least make the buttons quiet. The G4′s are fine.

    1. natalie hodge
      natalie hodge February 8, 2013 at 10:07 am | | Reply

      my daughter is 12 and also a podder/ G4 customer, she has same sentiments as your daughter, doesn’t give a crap about the two devices, a non issue, dex going to cell will bypass integration efforts, she doesn’t mind the two ” things on the body’ at all as I expected she would ( as our endo told us she might)

      she is just so damn happy to have the numbers all the time and to not get high and low so much and FEEL BAD.

      Isn’t it great these companies are fighting so hard for our business??

  7. pslab
    pslab February 5, 2013 at 10:04 am | | Reply

    Well … all of the above comments are true .. but you should think out of the box …. what if the canula and the sensor electrode can use one penetration spot … what if you do not need to warm up anymore .. what if the sensor and the pod combined are cheap enough so you do not need to worry …. The thing that bothers me is about the problem that the pods got now .. if insertion fails you lose the pod .. same goes with the new device .. if for some reason one of the TWO components fail … you lose the pod …. Thats the real troublemaker for me… but after all it’s all about the money … if its cheap enough .. everything will be OK

  8. Judi
    Judi February 5, 2013 at 12:26 pm | | Reply

    What are Amy’s thoughts on this, since she wears both a Pod & G4?

    1. AmyT
      AmyT February 5, 2013 at 4:49 pm | | Reply

      @Judi – thanks for asking. Yep, I’m an OmniPod and Dex G4 user. Frankly, I’m bummed that my two favorite (and IMHO the two best) diabetes technology companies out there are no longer collaborating. That duo would have been fantastic!

      That said, I’m sure not willing to switch to any tubed pump just because it’s paired with a CGM — even if it is a great Dexcom product.

      So I guess I’m forced to wait to see what kind of integration Insulet might come up with. In the meantime, I am wearing these 2 devices and struggling to find enough “real estate” to accommodate both.

  9. Chad
    Chad February 5, 2013 at 12:35 pm | | Reply

    I would place my bet on Insulet partnering with one of the next gen non-invasive sensors that are using spectroscopy to read BG as opposed to the current sensors that have a wire filament sitting under the skin. Possibly C8 medisensors, which is under regulatory review in Europe. If this new technology truns out to be accurate, it would be a great fit with Omnipod, as the sensor can be easily moved around without wasting supplies and the pod could easily house the large battery that is needed to power the C8.

  10. MommaKat
    MommaKat February 5, 2013 at 1:05 pm | | Reply

    Thank you for posting this today. I shared it with my daughter and she’s beyond sad. We both find the idea of an all in one site less than appealing. Integration with a smart phone – sure that sounds great. She’d like that as she moves toward HS and college. However, a two in one site that results in a cgm life of 3 days and the necessity of changing both one’s insulin site and cgm site should one of the two fail? Not sure who thought of that, but we both think they completely missed the boat. Too bad. I’m sure my kiddo isn’t the only one who’s decided she’ll now wait for the other tubeless pumps she saw at Expo to hit the market. Omnipod is, according to her, irrevocably off her list.

  11. David
    David February 5, 2013 at 2:45 pm | | Reply

    Could be good news for Roche Solo and CellNovo but they may delay their launches in order to integrate Dexcom *sigh*.

  12. Type1Engineer
    Type1Engineer February 5, 2013 at 7:43 pm | | Reply

    As for using Raman Spectroscopy–expect skin irritation!!!

    The news is not necessarily a bad thing. Insulet produced an innovative product, that was quite an engineering feat. The design is also refined and there is relatively low failure rate for the pods, when it comes to occlusions and other mechanical malfunctions. Aside from a tendency for the pods to fall off, I doubt the failure rate is more than a “traditional” insulin pump.

    I trust Insulet to make a better product than most other diabetes device manufacturers, including an integrated CGM/Pump–a CGMPod.

    There are all sorts of cool things that can come out, with the physical integration of the two devices. Such as, if you were going to change your old CGMPod at 80 hours and it logged your sensor BG continuously for the past X hours (i.e. probably around 3 hours) prior to the change, you could change to a new CGMPod and use those past X hours from the old pod as an “instant” calibration along with a meter BG (or more) to get “instant” and “continuous” readings from the actual CGM without disruption.

    Their strategy could also be a good way to get JDRF funding.

    But, Insulet’s software, is horrible, along with any software that deals with diabetes medical device data, including software using mobile devices and the cloud. Insulet’s software is only capable of operating on Windows, due to the .NET framework. Even if you were to get it running it in Parallels or VMWare Fusion on a Mac, the drivers would never work.

    The only current device for uploading diabetes device data that is powerful and efficient is the Accu-Chek Smart Pix. I can upload my data to my computer using the software stored INSIDE the Smart Pix USB device. I then open up the file it produces (which opens up in any web browser), save it as a TXT file, and I then run my data through MatLab on my netbook. It takes way less time than any other type of diabetes related software.

    Anyways, although the Accu-Chek Combo is not cosmetically attractive, it is appealing. Accu-Chek is on my short list for my next insulin pump.

    Anyways, if the Artificial Pancreas project is going to be truly successful, a medical device data storage AND communication is going to have to be used. If the JDRF funds such projects, a precondition should be made that ISO/IEEE 11073 must be used for all data and communication between all devices used in the Artificial Pancreas projects.

    Otherwise, the organization is just wasting donated money. Because, it is much harder to program and deal with proprietary data structures and communications–and it certainly costs more money. Also, analysis of the various AP clinical trials cannot be done as easily in Tandem.

  13. Matt
    Matt February 5, 2013 at 8:45 pm | | Reply

    I moved to Omnipod from Medtronic 4.5 years ago (after 5 with Medtronic) and will never go back to a convention (tubing) pump. I was really looking forward to the next generation integration, reducing the # of things in my pockets is a big sell. But my long term vision has always been an all in one device (one handheld and one site on the body). I just started on the Dex G4 (my first CGM ever) last month and can already say that while I love it I’m going to have to start getting creative with places to put these 2 devices on my body. One device would be a huge improvement. Additionally, I lead a very active lifestyle and even with using taping products like IV3000 or Tegaderm both my Pod and my sensor have a lot of issues with staying stuck on me. Long workouts and hot summer days play havoc with how long I can functionally use things, so to me the 80 hour lifespan isn’t really a big deal. Ultimately, with a potential 4 year development horizon, who’s to say that they might not even decide and develop the ability to transmit data to a smartphone as long as they’re at it.

  14. Insulet & Dexcom Break Up Over Plans for Next-Gen Integration « DiabetesNews

    [...] The two companies say they have abandoned the integration deal they had in place since 2008. Read more var dd_offset_from_content = 45; var dd_top_offset_from_content = 0; Category : Featured, [...]

  15. Scott S
    Scott S February 6, 2013 at 11:46 am | | Reply

    When I heard of this in the Insulet presentation at the J.P. Morgan Healthcare Conference in January, it actually made sense the way the company presented. Why bother working on integration when a bluetooth version that anyone can use will be in a future generation of the Dexcom? If you’re a company like Insulet, you obviously need to prioritize which projects you’ll invest time and resources into. Given Dexcom has been fairly public about the direction it plans to go, its a wonder other pump companies that have partnered with Dexcom aren’t already moving in the same direction.

  16. Bill
    Bill February 7, 2013 at 7:50 am | | Reply

    You mention four things to carry with current OmniPod and Dexcom CGM; pod, sensor, pdm, and cgm handeld or an intergrated pump. If you have an “intergrated” pump would you not have an infusion site w/tubing, a pump, a sensor, and a finger stick meter, which is required to bolus as well as calibrate your cgm? Also, if dexcom does go to an app for cell phones your back to tubless vs. tubed. Good article, just some thoughts.

  17. Daniele
    Daniele February 7, 2013 at 6:05 pm | | Reply

    I would like more a partnership with Echo Therapeutics. Think of a pod with a Simfony sensor on is flat side, which you insert as seen in the following video. The sensor works “down” while tha cannula inserts as usual on a side. I think it lasts around the 80 hours of the Pod.
    Otherwise, with a needle CGM, you could think to use a CGM Pod and after 3 days retract the canula, keep it going as CGM only and put a “simple” Pod for the other 3 days. You would have 2 Pods toghetrer on for 50% of the time, but it would work for sure.

  18. Insulet ditches DexCom in diabetes collaboration | Global Regulatory Science

    [...] – read the story [...]

  19. {Type 1 Tuesday} 03.12.13
    {Type 1 Tuesday} 03.12.13 March 12, 2013 at 5:01 am |

    [...] Mine Insulet & Dexcom Break Up Over Plans for Next-Gen Integration (Kind of a bummer! Click over and read all the great [...]

  20. Jacques Cattier
    Jacques Cattier March 22, 2013 at 12:03 pm | | Reply

    My understanding is that controlling a life critical medical device, such as an insulin pump, through a smartphone would never be approved by the FDA. How could they test cellular interference, communications on planes, and interaction with the numerous other pieces of software on a phone? I imagine that an additional friction point with Dexcom was determining whose customer the integrated device user would be.

    Hopeful that the interest of the diabetic will lead the technology development at Insulet.

  21. June S.
    June S. March 26, 2013 at 8:36 am | | Reply

    Very interesting … The OmniPod was my first pump, and I had major issues with both failed pods and infusion site absorption and (most importantly) allergy to the Pod adhesive, at least during the warmer weather here on the East coast. A 3-day sensor is ridiculous, in that I get 6 days out of my Medtronic sensors and note that the Medtronic sensors are becoming better. The past two I’ve used gave me very accurate readings after the first calibration! My endocrinologist does not allow any of her pumping patients to keep their infusion sites in for more than 2 days. That’s an individual things, but in my case it’s good advice. All the more reason for me to stick with Medtronic, despite the tubing.

    1. garidan
      garidan March 26, 2013 at 5:05 pm | | Reply

      It’s not strange: it all depends on I much time it takes to start working well after insertion and how much does it cost. It will be a new sensor so we cannot say anything now.
      As for Medtronic, here in Italy for the “new” Enlite sensor I read many nightmare experiences …..

  22. AANOas
    AANOas May 7, 2013 at 2:14 pm | | Reply

    i disagree, try inserting the sensor 24 hours in advance (make sure the top part is protected in the correct position using med tape.

  23. Tom P
    Tom P August 24, 2013 at 10:24 pm | | Reply

    An Integrated one site and one device for CGM and Insulin delivery would not only be worth the wait but the only option for people where medical insurance and government coverage does not cover CGM sensors but does cover insulin infusion devices and delivery pods. This is a way to disguise the package into one unit for the medical insurance and government insurance programs to finally cover CGM as it will be disguised into the insulin pump/pod they are already OK to cover.

  24. Fred
    Fred February 2, 2014 at 5:58 am | | Reply

    checkout my T1D daughters invention for omnipod insulin pumps http://www.kedzcovers com

  25. John
    John February 10, 2014 at 6:34 am | | Reply

    I’m a pod user and hope for a noninvasive cgsm pairing. I think the technology is there. If they can read oxygen saturation with a finger clip then why not BS?

    My biggest complaint with Omnipod is they have no Mac compatible software for tracking blood glucose tests which is a total failure on their part in support of T1′s.

    Their deal with Abbott needs to be revisited and I have filed a complaint with the FDA. Support for both Windows and Mac users should have been mandatory. That’s a cudos for Medtronic. How the FDA allowed this market (Mac) to be left behind is unconscionable.

Leave a Reply